Christoph W. Turck
|
Christoph W. Turck, Prof. Dr. rer. nat.Research group leader |
|
| Phone: | 089/30622-317 | |
| Fax: | 089/30622-610 | |
| Email: | turck[a]mpipsykl.mpg.de | |
| Interests: | Proteomic, Biomarker brain disease | |
| CV: Born in Homberg, Germany. PhD in chemistry, RWTH Aachen, Germany (1983). Postdoc, Roche Institute of Molecular Biology, Nutley, NJ, USA (1983-1986). Professor of Medicine, Director of Protein Structure Laboratory, University of California San Francisco, Howard Hughes Medical Institute (1986-2002). Since 2002, Research group leader, Proteomics and Biomarkers, MPI of Psychiatry. |
||
Further activities:
|
||
| Selected publications: Ditzen, C, Varadarajulu, J, Czibere, L, Gonik, M, Targosz, BS, Hambsch, B, Bettecken, T, Keßler,,MS, Frank, E, Bunck, M, Teplytska, L, Erhardt, A, Holsboer, F, Müller-Myhsok, B, Landgraf, R, Turck, CW. (2009) Proteomic-based genotyping in a mouse model of trait anxiety exposes disease-relevant pathways. Mol Psychiatry el. (EPub ahead to print) Nguyen, JT, Turck, CW, Cohen, FE, Zuckermann, RN and Lim, WA. (1998) Exploiting the basis of proline recognition by SH3 and WW domains: design of N-substituted inhibitors. Science 282:2088-2092 Wang, L-Y, Edenson, SP, Yu, Y-L, Senderowicz, L and Turck, CW. (1996) A natural kinase-deficient variant of fibroblast growth factor receptor 1. Biochemistry 35: 10134-10142 Kavanaugh, WM, Turck, CW and Williams, LT. (1995) PTB domain binding to signaling proteins through phosphotyrosine in a unique sequence motif. Science 268:1177-1179 Yu, Y-L, Kha, H, Golden, JA, Migchielsen, AAJ, Goetzl, EJ and Turck, CW. (1992) An acidic fibroblast growth factor protein generated by alternate splicing acts like an antagonist. J Exp Med 175:1073-1080 |
||


